Lumazine synthase
class of enzymes
Lumazine synthase (EC 2.5.1.78, 6,7-dimethyl-8-ribityllumazine synthase, 6,7-dimethyl-8-ribityllumazine synthase 2, 6,7-dimethyl-8-ribityllumazine synthase 1, lumazine synthase 2, lumazine synthase 1, type I lumazine synthase, type II lumazine synthase, RIB4, MJ0303, RibH, Pbls, MbtLS, RibH1 protein, RibH2 protein, RibH1, RibH2) is an enzyme with systematic name 5-amino-6-(D-ribitylamino)uracil butanedionetransferase. This enzyme catalyses the following chemical reaction
1-deoxy-L-erythrulose 4-phosphate + 5-amino-6-(D-ribitylamino)uracil
⇌
{\displaystyle \rightleftharpoons }
6,7-dimethyl-8-(D-ribityl)lumazine + 2 H2O + phosphate
This reaction is part of the biosynthesis of riboflavin (vitamin B2). Lumazine synthase is thus found in those organisms (plants, fungi and most microorganisms) which produce riboflavin.
Depending on the species, 5, 10 or 60 copies of the enzyme bind together to form homomers. In the case of 60 copies, the enzyme units form a icosahedral hollow cage. In some bacteria, this cage contains another enzyme involved in the riboflavin synthesis, riboflavin synthase.
These icosahedral cages have been investigated for use in drug delivery or as vaccines, delivering antigens. Using directed evolution, Lumazine synthase has been modified so that it forms larger cages that preferentially package RNA molecules that code for the protein, akin to a virus capsid.
The public source identifies “Lumazine synthase” as class of enzymes. This brief keeps that definition visible, then builds a research path around Lumazine, synthase and class.
Why this record matters
A short description can identify a subject without explaining its stakes. For “Lumazine synthase”, the useful work is to connect “class of enzymes” to the records capable of establishing context and consequence.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated May 3, 2026. The linked authority identifier is Q6703047. None of the 0 selected statements returned an explicit reference.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Lumazine synthase”, its source revision and the description used here.
- Expand the search: follow Lumazine synthase primary sources, Lumazine synthase archive and Lumazine research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Lumazine synthase”?
- Which institution is responsible for the underlying evidence?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “Lumazine synthase” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.